Clinical application of single nucleotide polymorphism array in prenatal diagnosis: Experience with 8753 samples
PLOS One · 2025
DOI: 10.1371/journal.pone.0332424 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Li Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal diagnosis and screening center, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zheji…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Prenatal Diagnosis, Chromosome Disorders. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Construction Fund of Key Medical Disciplines of Hangzhou.
Abstract (Originalsprache)
Background
Single nucleotide polymorphism (SNP) array has been applied to prenatal diagnosis. This study aimed to assess the clinical significance of SNP array in diagnosing fetal chromosomal anomalies based on our experience.
Methods
A total of 8753 pregnant women with high-risk prenatal indications were enrolled in this retrospective study. Demographic characteristics, chromosomal abnormalities and follow-up results were collected.
Results
Data showed that the overall abnormality detection rate of SNP array was 16.9%, including the detection rate of 7.7% in aneuploidy, the detection rate of 4.2% and 4.4% in pathogenic copy number variations (CNVs) and variants of uncertain significance. The total abnormality detection rate was 15.3%, 22.0% and 38.4% for pregnant women with single risk indication, two kinds of indications and more than two kinds of indications, respectively. The detection rates in the three groups were statistically significant. Additionally, fetus with the positive noninvasive prenatal testing (NIPT) results had the highest abnormality detection rate (38.8%), followed by participants with the abnormal ultrasound findings (13.1%). 98.8% of pregnant women simultaneously chose traditional karyotyping and got their karyotype results. The concordant rate between karyotyping and SNP array was 89.0%, with some structural abnormalities and low-level mosaicism being missed by SNP array, while SNP array additionally found the microduplication/microdeletion.
Conclusions
SNP array would be a valuable technology in prenatal diagnosis, with different abnormality detection rate in pregnant women with various risk indications. SNP array combined with the traditional karyotyping could provide more information for prenatal diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Prenatal diagnosis and screening center, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, China.
ORCID-Profile: Xiangjuan Li
Förderung
- Construction Fund of Key Medical Disciplines of Hangzhou
Zitieren
APA
Wen, L., Zhang, Y., Zhang, W., Mao, A., & Li, X. (2025). Clinical application of single nucleotide polymorphism array in prenatal diagnosis: Experience with 8753 samples. PLOS One. https://doi.org/10.1371/journal.pone.0332424
Vancouver
Wen L, Zhang Y, Zhang W, Mao A, Li X. Clinical application of single nucleotide polymorphism array in prenatal diagnosis: Experience with 8753 samples. PLOS One. 2025. doi:10.1371/journal.pone.0332424
BibTeX
@article{Wen2025,
author = {Wen, Li and Zhang, Yanzhen and Zhang, Wen and Mao, Aifen and Li, Xiangjuan},
title = {Clinical application of single nucleotide polymorphism array in prenatal diagnosis: Experience with 8753 samples},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332424}
}
EUVIMED